SIAH-2 Antibodies

Santa Cruz Biotechnology provides a broad selection of SIAH-2 monoclonal antibodies for research focused on understanding SIAH-2's role in cellular processes. SIAH-2 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). SIAH-2, or seven in absentia homolog 2, functions as a critical E3 ubiquitin ligase involved in the regulation of protein degradation and cellular signaling pathways. SIAH-2 plays a significant role in the cellular response to stress and has been implicated in various diseases, including cancer. Research has shown that SIAH-2 activity influences multiple cellular pathways and biological processes. Understanding SIAH-2 function is essential for elucidating its contributions to tumorigenesis and other pathological conditions. Investigating SIAH-2's molecular mechanisms can provide valuable insights into potential therapeutic targets. Current research continues to uncover new roles for SIAH-2 in cellular regulation and disease progression. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of SIAH-2's role in human health and disease.